1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Coronary Syndrome: new trials by email Literature Review of Coronary Syndrome trials Research Report on Coronary Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Randomized OPTIMAL-ACT Trial Unfractionated heparin - Coronary Artery Disease, Ischemic Heart Disease | Phase 2 | Completed | Mayo Clinic | 180 | 2019-02-08 | 2023-04-04 |
| The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease Rosuvastatin, Olmesartan, Combination - Coronary Syndrome | Phase 2 | Unknown | Samsung Medical Center | 504 | 2015-08-01 | 2015-08-06 |
Angina, Unstable (2) · Coronary Artery Disease (1) · Hemorrhage (1) · Myocardial Ischemia (1)
Angina Pectoris (2) · Cardiovascular Diseases (2) · Chest Pain (2) · Heart Diseases (2) · Neurologic Manifestations (2) · Pain (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Coronary Disease (1) · Myocardial Ischemia (1) · Pathologic Processes (1)
Heparin (1) · Rosuvastatin Calcium (1) · olmesartan (1)
Mayo Clinic (1) · Samsung Medical Center (1)
South Korea (1) · United States (1)
Hyeon-Cheol Gwon, PhD (1) · Shahyar M Gharacholou, MD, MSc (1)